OncoSec Medical Receives VBHRC Funding to Study Novel Gene Therapy Approach in Melanoma

OncoSec Medical Inc. , a company developing DNA-based intratumoral cancer immunotherapies, along with researchers at Old Dominion University and Eastern Virginia



from Content Keyword RSS http://ift.tt/10KSOfd

via IFTTT